(VIANEWS) - CRISPR Therapeutics AG (CRSP), Enova International (ENVA), Danaher Corporation (DHR) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. CRISPR Therapeutics AG (CRSP)
46.5% sales growth and 21.36% return on equity
CRISPR Therapeutics AG, a gene editing company, focuses on developing transformative gene-based medicines for serious human diseases.
CRISPR Therapeutics AG's sales growth this year is expected to be 119346% and a negative 97.1% for next year.
Year-on-year quarterly revenue growth grew by 456.8%, now sitting on 902.43M for the twelve trailing months.
Volume
Today's last reported volume for CRISPR Therapeutics AG is 2738240 which is 66.46% above its average volume of 1644970.
CRISPR Therapeutics AG's sales growth for the next quarter is 46.5%. The company's growth estimates for the ongoing quarter and the next is a negative 18% and negative -19.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 21.36%.
Volatility
CRISPR Therapeutics AG's last day, last week, and last month's current intraday variation average was 0.41%, 2.89%, and 3.37%, respectively.
CRISPR Therapeutics AG's highest amplitude of average volatility was 8.90% (day), 9.83% (last week), and 7.65% (last month), respectively.
CRISPR Therapeutics AG's Stock Yearly Top and Bottom Value
CRISPR Therapeutics AG's stock is valued at $59.00 at 19:22 EST, way below its 52-week high of $175.44 and above its 52-week low of $55.35.
CRISPR Therapeutics AG's Moving Average
CRISPR Therapeutics AG's value is way under its 50-day moving average of $73.72 and way under its 200-day moving average of $106.76.2. Enova International (ENVA)
37.4% sales growth and 51.42% return on equity
Enova International, Inc., a technology and analytics company, provides online financial services.
Enova International's sales growth this year is expected to be 10.5% and 33.3% for next year.
Year-on-year quarterly revenue growth grew by 39.9%, now sitting on 902.59M for the twelve trailing months.
Volume
Today's last reported volume for Enova International is 29454 which is 91.72% below its average volume of 356091.
Enova International's sales growth for the next quarter is 37.4%. The company's growth estimates for the present quarter and the next is a negative 49% and negative -39.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 51.42%.
Volatility
Enova International's last day, last week, and last month's current intraday variation average was 6.39%, 2.22%, and 1.64%, respectively.
Enova International's highest amplitude of average volatility was 7.19% (day), 3.68% (last week), and 3.09% (last month), respectively.
Enova International's Stock Yearly Top and Bottom Value
Enova International's stock is valued at $41.76 at 19:22 EST, below its 52-week high of $44.43 and way higher than its 52-week low of $22.01.
Enova International's Moving Average
Enova International's worth is above its 50-day moving average of $40.33 and way above its 200-day moving average of $35.67.3. Danaher Corporation (DHR)
12.5% sales growth and 13.98% return on equity
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide.
Danaher Corporation's sales growth this year is expected to be 28.7% and 5.4% for next year.
Year-on-year quarterly revenue growth grew by 36.3%, now sitting on 26.72B for the twelve trailing months.
Volume
Today's last reported volume for Danaher Corporation is 1381200 which is 54.17% below its average volume of 3014280.
Danaher Corporation's sales growth is a negative 0% for the ongoing quarter and 12.5% for the next. The company's growth estimates for the present quarter and the next is 25% and 14.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.98%.
Volatility
Danaher Corporation's last day, last week, and last month's current intraday variation average was 1.60%, 1.74%, and 1.74%, respectively.
Danaher Corporation's highest amplitude of average volatility was 2.03% (day), 2.35% (last week), and 2.70% (last month), respectively.
Danaher Corporation's Stock Yearly Top and Bottom Value
Danaher Corporation's stock is valued at $287.63 at 19:22 EST, way below its 52-week high of $333.96 and way above its 52-week low of $211.22.
Danaher Corporation's Moving Average
Danaher Corporation's value is under its 50-day moving average of $308.14 and higher than its 200-day moving average of $279.31.4. SVB Financial Group (SIVB)
9.8% sales growth and 18.59% return on equity
SVB Financial Group's sales growth this year is anticipated to be 38% and 2.1% for next year.
Year-on-year quarterly revenue growth grew by 37%, now sitting on 5.59B for the twelve trailing months.
Volume
Today's last reported volume for SVB Financial Group is 461264 which is 11.35% above its average volume of 414235.
SVB Financial Group's sales growth for the next quarter is 9.8%. The company's growth estimates for the present quarter and the next is a negative 40.3% and negative -11.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 18.59%.
Volatility
SVB Financial Group's last day, last week, and last month's current intraday variation average was 2.05%, 2.37%, and 2.73%, respectively.
SVB Financial Group's highest amplitude of average volatility was 3.65% (day), 4.34% (last week), and 5.27% (last month), respectively.
SVB Financial Group's Stock Yearly Top and Bottom Value
SVB Financial Group's stock is valued at $613.31 at 19:22 EST, way below its 52-week high of $763.22 and way higher than its 52-week low of $349.48.
SVB Financial Group's Moving Average
SVB Financial Group's value is way below its 50-day moving average of $714.23 and higher than its 200-day moving average of $599.78.5. Martin Marietta Materials (MLM)
7.9% sales growth and 12.03% return on equity
Martin Marietta Materials, Inc., a natural resource-based building materials company, supplies aggregates and heavy building materials to the construction industry in the United States and internationally.
Martin Marietta Materials's sales growth this year is anticipated to be 10.2% and 7.7% for next year.
Year-on-year quarterly revenue growth grew by 17.9%, now sitting on 4.79B for the twelve trailing months.
Volume
Today's last reported volume for Martin Marietta Materials is 321877 which is 15.39% below its average volume of 380437.
Martin Marietta Materials's sales growth for the next quarter is 7.9%. The company's growth estimates for the current quarter and the next is a negative 8.5% and negative -3.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.03%.
Volatility
Martin Marietta Materials's last day, last week, and last month's current intraday variation average was 3.82%, 1.97%, and 1.71%, respectively.
Martin Marietta Materials's highest amplitude of average volatility was 3.25% (day), 2.59% (last week), and 3.41% (last month), respectively.
Martin Marietta Materials's Stock Yearly Top and Bottom Value
Martin Marietta Materials's stock is valued at $372.05 at 19:22 EST, way under its 52-week high of $439.98 and way higher than its 52-week low of $258.18.
Martin Marietta Materials's Moving Average
Martin Marietta Materials's worth is below its 50-day moving average of $396.62 and higher than its 200-day moving average of $366.38.6. Equifax (EFX)
5.9% sales growth and 21.56% return on equity
Equifax Inc. provides information solutions and human resources business process outsourcing services for businesses, governments, and consumers.
Equifax's sales growth this year is anticipated to be 16.7% and 6.3% for next year.
Year-on-year quarterly revenue growth grew by 14.5%, now sitting on 4.79B for the twelve trailing months.
Volume
Today's last reported volume for Equifax is 923157 which is 7.91% above its average volume of 855459.
Equifax's sales growth for the next quarter is 5.9%. The company's growth estimates for the current quarter and the next is a negative 8% and negative -11%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 21.56%.
Volatility
Equifax's last day, last week, and last month's current intraday variation average was 5.02%, 2.70%, and 2.34%, respectively.
Equifax's highest amplitude of average volatility was 4.41% (day), 2.83% (last week), and 3.77% (last month), respectively.
Equifax's Stock Yearly Top and Bottom Value
Equifax's stock is valued at $234.07 at 19:22 EST, way under its 52-week high of $296.63 and way higher than its 52-week low of $161.87.
Equifax's Moving Average
Equifax's value is way below its 50-day moving average of $275.65 and below its 200-day moving average of $242.45.Previous days news about Equifax(EFX)
- According to CNBC on Wednesday, 2 February, "In most cases, thieves didn't hack the unemployment system for personal data, Evermore said - they got it from past data breaches, like the one that impacted the crediting reporting company Equifax in 2017."